# Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center

> **NCT01311388** · — · UNKNOWN · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 1500 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01311388
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** —
- **Final completion:** 2013-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311388, "Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01311388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*